XML 51 R40.htm IDEA: XBRL DOCUMENT v3.25.4
Accrued Expenses and Other Liabilities (Details) - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Accrued Expenses and Other Liabilities    
Accrued marketing expenses $ 999,996 $ 999,996
Compensation and related benefits 1,265,088 298,090
Accrued preclinical and clinical trial expenses 364,460 364,460
Advance payments received from customers for manufacturing materials 169,758 169,758
Other expenses 81,908 268,161
Accrued manufacturing expenses   59,793
Total $ 2,881,210 $ 2,160,258